Edesa Biotech Inc. (EDSA) is a clinical-stage biopharmaceutical firm based in Markham, Canada, dedicated to developing advanced therapies for inflammatory and immune-related disorders. The company boasts a promising pipeline that leverages proprietary technologies to enhance treatment options, particularly in dermatological and gastrointestinal diseases, addressing critical unmet medical needs. With several ongoing clinical trials and a strong emphasis on improving patient outcomes, Edesa is strategically positioned to make significant advancements in the biotherapeutics arena, aiming to expand its influence within the healthcare sector. Show more
Location: 100 SPY COURT, MARKHAM, ON, CANADA, L3R 5H6, Markham, ON, L3R 5H6, USA | Website: https://www.edesabiotech.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
9.751M
52 Wk Range
$1.09 - $4.49
Previous Close
$1.23
Open
$1.24
Volume
272,743
Day Range
$1.09 - $1.25
Enterprise Value
9.233M
Cash
10.79M
Avg Qtr Burn
-1.766M
Insider Ownership
16.93%
Institutional Own.
34.42%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Paridiprubart (EB05) Details Acute Respiratory Distress Syndrome (ARDS) | Phase 3 Update |
